wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37234627-E97B7A0D-396F-4562-8F52-E49CD5E41D96
Q37234627-E97B7A0D-396F-4562-8F52-E49CD5E41D96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37234627-E97B7A0D-396F-4562-8F52-E49CD5E41D96
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma.
P2860
Q37234627-E97B7A0D-396F-4562-8F52-E49CD5E41D96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37234627-E97B7A0D-396F-4562-8F52-E49CD5E41D96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c9d016163e74c7e69df47e7556e2310be0d287ed
P2860
Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics.